Effect of COVID-19 on Liver Enzymes

Abstract

So far, scientific data has confirmed that the at-risk group with increased likelihood and severe course of infection with the Coronavirus includes elderly patients and patients with chronic cardiovascular diseases such as high blood pressure, coronary heart disease and diabetes. Little is known about the effects of other chronic diseases, particularly liver disease. However, it is already clear that patients with severe cirrhosis and cirrhosis, and patients after liver transplantation are also a group at increased risk of infection and a severe course of COVID-19. Therefore, they are strictly described as self-isolation and reduced social contacts.

We analyzed the available data on the effect of SARS-CoV-2 infection on the course of chronic liver disease and made preliminary conclusions Published in Guidelines for Physicians Treating Patients with Liver Disease, it contains basic principles for medical tactics during a pandemic. We bring to your attention these recommendations in a summary.